Vyznova is under clinical development by Aurion Biotechnologies and currently in Phase II for Corneal Edema. According to GlobalData, Phase II drugs for Corneal Edema does not have sufficient ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the ...

The rate of endothelial cell loss (ECL) was calculated as the difference between preoperative and postoperative ECD. Postoperative complications, including corneal edema, elevated IOP, vitreous ...

In May 2023, results of a phase 2 study of 49 subjects with corneal edema were presented, showing faster visual recovery in the active treatment group (Baartman et al). Cells may be derived from ...

HYDROPS fetalis associated with hemoglobin Barts is believed to represent the homozygous state of α thalassemia. Ten cases occurring in Chinese families in Indonesia, Malaya and Hong Kong, 1 in a ...

In this case report we present a patient with displaced donor graft after DSAEK and associated peripheral corneal edema that resolved without any further intervention three months postoperatively.

The final, formatted version of the article will be published soon. Introduction & Importance -Secondary endolymphatic hydrops (SEH) is a pathologic condition of the inner ear that usually manifests ...

an allogeneic cell therapy product candidate for the treatment of corneal edema secondary to corneal endothelial dysfunction. AURN001 is a combination cell therapy product candidate comprised of ...

Standards and guidelines for development co-operation with concrete examples of their implementation ...